Xiaolong Liu, Mengxiao HE, Rongbo HU, Sihang HUANG and Zhencheng CHEN* Pages 1 - 15 ( 15 )
Cardiovascular disease is a major global public health challenge. Point-of-- care testing (POCT) technologies are crucial for the prevention, early diagnosis, and treatment of cardiovascular conditions. Numerous POCT technologies for cardiovascular disease are currently available, which include but are not limited to conventional methods, paper-based microfluidic technology, microfluidic chip technology, electrochemical detection technology, ultrasonic detection technology, and smartphone-based detection technology. Each method has a broad range of applications and performs differently across various detection scenarios. This article offers a comprehensive analysis of current POCT technologies for cardiovascular disease, assessing their effectiveness, limitations, and future development directions. The aim is to provide insights and theoretical references for innovative research and clinical applications in POCT methods for cardiovascular disease.
Cardiovascular disease, point-of-care testing, paper-based microfluidic, microfluidic chip, electrochemical detection, ultrasonic detection, smartphone-based detection.